# OnCo record utidelone (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/utidelone/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "utidelone" ;
  schema:name "Utidelone"@en ;
  schema:alternateName "Youheng"@en ;
  schema:description "Utidelone is Biostar Pharmaceuticals' epothilone chemotherapy, approved in China in 2021 with capecitabine for advanced breast cancer after anthracyclines and taxanes."@en ;
  schema:url <https://onco.cc/drugs/utidelone/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=utidelone> ;
  onco:status "approved" ;
  onco:tag "china", "nmpa-approved" ;
  onco:modality "Epothilone analogue, microtubule-stabilising cytotoxic chemotherapy" ;
  onco:approval "CN 2021: Recurrent or metastatic breast cancer after anthracycline and taxane, with capecitabine" ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:targets <https://onco.cc/targets/tubulin/> ;
  onco:companies <https://onco.cc/companies/biostar-pharmaceuticals/> .